Clinical Trials · NCT05965908

Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome

CompletedPhase 3Liraglutide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Beni-Suef University
Enrollment
183
Start date
Aug 2024
Locations
1 site, Egypt
Primary endpoint
Insulin Resistance (HOMA-IR)
View Liraglutide compound reference